Novo Nordisk partners Amazon on London AI hub
7 Articles
7 Articles
Novo Nordisk announced a partnership with Amazon Web Services (AWS), marking another collaboration between pharmaceutical and technology companies to use artificial intelligence (AI) in accelerating the discovery of new medicines. Exclusive material for subscribers. To have full access, access the link of the material and register.
Novo Nordisk and AWS enter strategic partnership to accelerate drug discovery through AI
New AI co-innovation hub in London brings together AWS engineers, AI specialists, and applied scientists alongside Novo Nordisk research and development teams to increase productivity and help reduce the time to market for future medicines.Agreement establishes AWS as Novo Nordisk's preferred cloud provider and strategic AI partner to accelerate drug discovery and modernise its technology infrastructure, preparing for the next generation of medi…
Blockonomi
BITRSSNovo Nordisk A/S (NVO) Stock: AWS AI Partnership Targets Faster Drug Discovery
TLDR Novo Nordisk names AWS its preferred cloud and strategic AI partner worldwide. Novo and AWS open a London innovation hub focused on faster drug discovery. AWS tools will support drug targeting, therapy design, and clinical data work. More than 25,000 Novo employees have already used tools from the partnership. NVO stock traded at $47.26, up 0.01%, after recovering from an early decline. Novo Nordisk (NVO) selected Amazon Web Services as it…
Novo Nordisk, a pharmaceutical laboratory, selects Amazon Web Services (AWS) as its preferred cloud provider and strategic partner in artificial intelligence. The Danish laboratory wants to use the Cloud and the AI to accelerate the discovery of medicines and modernize its IT infrastructure. (more...)This article Novo Nordisk's laboratory relies on AWS for the transformation of its pharmaceutical research appeared first on The Digital Review.
Novo Nordisk has established a new division in London together with Amazon Web Services (AWS), where employees from both companies will use Amazon’s AI to develop Novo Nordisk’s medicines. Novo Nordisk writes in a press release, describing the new division as a “co-innovation hub”.
Coverage Details
Bias Distribution
- 67% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
